Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis

MeSH terms

• Adult
• Amphotericin B / therapeutic use
• Antifungal Agents / therapeutic use
• Benzoates / pharmacology*
• Brain Stem / microbiology
• Brain Stem / pathology
• Caspofungin
• Cavernous Sinus / microbiology
• Cavernous Sinus / pathology
• Central Nervous System Fungal Infections / drug therapy*
• Central Nervous System Fungal Infections / microbiology
• Central Nervous System Fungal Infections / pathology
• Deferasirox
• Diabetic Ketoacidosis / complications
• Drug Therapy, Combination
• Echinocandins
• Humans
• Iron Chelating Agents / therapeutic use*
• Lipopeptides
• Magnetic Resonance Imaging
• Male
• Mucormycosis / drug therapy*
• Mucormycosis / microbiology
• Mucormycosis / pathology
• Nose Diseases / drug therapy*
• Nose Diseases / microbiology
• Peptides, Cyclic / therapeutic use
• Salvage Therapy*
• Triazoles / pharmacology*